Application 217814
- Type
- ANDA
- Sponsor
- RELIANCE LIFE SCI
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DECITABINE | DECITABINE | INJECTABLE;INTRAVENOUS | 50MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217814-001 | DECITABINE | DECITABINE | 50MG/VIAL | INJECTABLE / INTRAVENOUS | AP | 2025-12-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217814-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A217814-001 | DECITABINE | 50MG/VIAL | INJECTABLE / INTRAVENOUS | AP | 2025-12-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217814-001 | DECITABINE | 50MG/VIAL | INJECTABLE / INTRAVENOUS | AP | 2025-12-19 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217814-001 | DECITABINE | 50MG/VIAL | INJECTABLE / INTRAVENOUS | AP | 2025-12-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A217814-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217814-001 | AP | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217814-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Decitabine | DECITABINE | Bryant Ranch Prepack | c731a9f0-46ee-41c3-8f89-179cab13bdd2 | 2026-05-06 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Dr. Reddy's Laboratories Inc. | 358764ca-4c69-d516-af0c-bf8a348d26ca | 2026-03-25 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Dr.Reddy's Laboratories Limited | 4e1f4eb4-19b2-eee8-3402-bd2ccf622791 | 2026-03-25 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Meitheal Pharmaceuticals Inc. | a535a235-e1d2-4520-93fe-b7dd9b047784 | 2025-12-15 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | BluePoint Laboratories | de303068-589e-4e0a-90ed-e60b2c1a2b56 | 2025-09-29 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | BluePoint Laboratories | 00caa305-fef4-471b-b9c3-4bcf5fe7b244 | 2025-08-05 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Meitheal Pharmaceuticals Inc. | a3771445-1c68-4883-a014-74f8793f3136 | 2025-07-23 | Warnings, Adverse reactions | Decitabine DECITABINE |
| decitabine | DECITABINE | Hikma Pharmaceuticals USA Inc. | 8c5d6067-16a1-43ab-9e52-a33c600a5c44 | 2024-12-26 | Warnings, Adverse reactions | decitabine DECITABINE |
| Decitabine | DECITABINE | Accord Healthcare Inc. | b46df7d7-d98e-4c7e-b1ee-e03e258781c4 | 2024-07-09 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Camber Pharmaceuticals, Inc. | 5662c353-05d0-4bd8-87e4-c92ec9ca861e | 2024-06-26 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Eugia US LLC | a99f92cf-88f9-469b-aa69-44831e0bd4ab | 2023-07-29 | Warnings, Adverse reactions | Decitabine DECITABINE |
| DECITABINE | DECITABINE | BluePoint Laboratories | 6c6ab831-6234-4803-8a01-5c51ec3b0716 | 2023-05-26 | Warnings, Adverse reactions | DECITABINE DECITABINE |
| DECITABINE | DECITABINE | Nivagen Pharmaceuticals, Inc. | 150537a8-10ac-422d-bf33-68b1a408e566 | 2022-02-28 | Warnings, Adverse reactions | DECITABINE DECITABINE |
| Decitabine | DECITABINE | Qilu Pharmaceutical Co., Ltd. | 5b2dce6f-c715-47dc-971e-06244ccd7548 | 2021-10-18 | Warnings, Adverse reactions | Decitabine DECITABINE |
| decitabine | DECITABINE | Gland Pharma Limited | 39a26b24-e9d4-4974-9788-d025c51fc94f | 2021-09-15 | Warnings, Adverse reactions | decitabine DECITABINE |
| Decitabine | DECITABINE | Amneal Pharmaceuticals LLC | 40e7ef72-8df5-4adf-a269-4ae1c26eb6f9 | 2021-02-12 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Novadoz Pharmaceuticals LLC | a1b43089-bc88-4ac6-bdee-9cc38ec30f4e | 2021-01-01 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Northstar Rx LLC | 1abbe952-58bc-4dbc-b06a-fb79167bcd66 | 2020-08-17 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Novadoz Pharmaceuticals LLC | ae6c4580-3a3a-4c42-903a-1565d79521f8 | 2020-08-01 | Warnings, Adverse reactions | Decitabine DECITABINE |
| Decitabine | DECITABINE | Mylan Institutional LLC | 447a9fbd-106d-4ff6-8fd0-bb38a8c90e17 | 2020-07-26 | Warnings, Adverse reactions | Decitabine DECITABINE |